These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16618886)

  • 1. Treatment of precancerous and cancerous lesions of chronic arsenicism with 5% imiquimod cream.
    Boonchai W
    Arch Dermatol; 2006 Apr; 142(4):531-2. PubMed ID: 16618886
    [No Abstract]   [Full Text] [Related]  

  • 2. Imiquimod cream 5% for the treatment of arsenic-induced cutaneous neoplasms.
    Lonergan CL; McNamara EK; Cordoro KM; Greer KE
    Cutis; 2010 Apr; 85(4):199-202. PubMed ID: 20486460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical imiquimod to treat intraepidermal carcinoma.
    Hengge UR; Stark R
    Arch Dermatol; 2001 Jun; 137(6):709-11. PubMed ID: 11405756
    [No Abstract]   [Full Text] [Related]  

  • 4. Topical therapy for actinic keratoses, I: 5-Fluorouracil and imiquimod.
    Tutrone WD; Saini R; Caglar S; Weinberg JM; Crespo J
    Cutis; 2003 May; 71(5):365-70. PubMed ID: 12769403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six cases.
    Stockfleth E; Meyer T; Benninghoff B; Christophers E
    Br J Dermatol; 2001 May; 144(5):1050-3. PubMed ID: 11359396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicentre, open-label study using imiquimod 5% cream in one or two 4-week courses of treatment for multiple actinic keratoses on the head.
    Stockfleth E; Sterry W; Carey-Yard M; Bichel J
    Br J Dermatol; 2007 Dec; 157 Suppl 2():41-6. PubMed ID: 18067631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trials.
    Korman N; Moy R; Ling M; Matheson R; Smith S; McKane S; Lee JH
    Arch Dermatol; 2005 Apr; 141(4):467-73. PubMed ID: 15837864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New therapy update: ALDARA (imiquimod cream, 5%).
    Abramovits W; Gupta AK
    Skinmed; 2004; 3(4):215. PubMed ID: 15249782
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment of keratoacanthoma and actinic keratoses with imiquimod 5% cream.
    Peris K; Micantonio T; Fargnoli MC
    Eur J Dermatol; 2003; 13(4):413-4; author reply 415. PubMed ID: 12948930
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% imiquimod cream in the treatment of actinic keratosis.
    Kose O; Koc E; Erbil AH; Caliskan E; Kurumlu Z
    J Dermatolog Treat; 2008; 19(3):159-63. PubMed ID: 18569272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical treatment strategies for non-melanoma skin cancer and precursor lesions.
    McGillis ST; Fein H
    Semin Cutan Med Surg; 2004 Sep; 23(3):174-83. PubMed ID: 15584683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multiple bowenoid arsenic keratoses].
    Leyh F; Rothlaender JP
    Derm Beruf Umwelt; 1985; 33(3):99-101. PubMed ID: 4028974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imiquimod and lymphatic field clearance: a new hypothesis based on a remote immune action on skin cancer.
    Akkilic-Materna M; Massone C; Komericki P
    Acta Derm Venereol; 2011 Jun; 91(4):432-5. PubMed ID: 21547348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin cancer induced by arsenic in the water.
    Cabrera HN; Gómez ML
    J Cutan Med Surg; 2003; 7(2):106-11. PubMed ID: 12447618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of multiple actinic keratoses in organ transplant patients with topical 5% imiquimod: a report of six cases.
    Ulrich C; Busch JO; Meyer T; Nindl I; Schmook T; Sterry W; Stockfleth E
    Br J Dermatol; 2006 Aug; 155(2):451-4. PubMed ID: 16882188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients: randomized, double-blind, placebo-controlled trial.
    Brown VL; Atkins CL; Ghali L; Cerio R; Harwood CA; Proby CM
    Arch Dermatol; 2005 Aug; 141(8):985-93. PubMed ID: 16103328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of arsenic in drinking-water and cutaneous lesions in Inner Mongolia.
    Guo X; Liu Z; Huang C; You L
    J Health Popul Nutr; 2006 Jun; 24(2):214-20. PubMed ID: 17195562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dosing frequency on the safety and efficacy of imiquimod 5% cream for treatment of actinic keratosis on the forearms and hands: a phase II, randomized placebo-controlled trial.
    Gebauer K; Shumack S; Cowen PS
    Br J Dermatol; 2009 Oct; 161(4):897-903. PubMed ID: 19545297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imiquimod 5 percent cream and the treatment of cutaneous malignancy.
    Navi D; Huntley A
    Dermatol Online J; 2004 Jul; 10(1):4. PubMed ID: 15347486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imiquimod 5% cream in the treatment of mycosis fungoides--a pilot study.
    Chong A; Loo WJ; Banney L; Grant JW; Norris PG
    J Dermatolog Treat; 2004 Apr; 15(2):118-9. PubMed ID: 15204164
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.